Mitozolomide

From WikiMD's WELLNESSPEDIA

Mitozolomide

Mitozolomide




Chemical nomenclature
IUPAC name 3-(2-chloroethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide










Identifiers
CAS Number 85622-95-3
PubChem 71766


ChemSpider 64805
UNII E3U7286V3W


ChEMBL 435951
Chemical data


Chemical formula C7H7N6O2Cl1
Molecular weight 242.622 g/mol
SMILES NC(=O)c1ncn2C(=O)N(CCCl)\N=N/c12
InChI 1S/C7H7ClN6O2/c8-1-2-14-7(16)13-3-10-4(5(9)15)6(13)11-12-14/h3H,1-2H2,(H2,9,15)
InChIKey QXYYYPFGTSJXNS-UHFFFAOYSA-N

Mitozolomide (INN) is an antineoplastic. It is an imidazotetrazine derivative.

Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression.[1] Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.[2]

References[edit]

  1. "Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomide".Cancer Gene Ther.February 2000;7(2)
    233–9.doi:10.1038/sj.cgt.7700120.PMID:10770631.Full text.
  2. "Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)".Br J Cancer.February 1992;65(2)
    287–91.doi:10.1038/bjc.1992.57.PMID:1739631.PMC:1977719.


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.